
Pharma Pulse 8/26/24: Transforming Pharma Supply Chains for Personalized Care, Are You Mentally Fit to Lead? & more
The latest news for pharma industry insiders.
A prediction of how this shift toward patient-centric care may look.
The Alzheimer disease treatment landscape is evolving with new FDA-approved antibody therapies and advancements in biomarker testing to enable earlier diagnosis and intervention.
Artificial intelligence could soon be used to suggest executives are in cognitive decline—and help them ward off scrutiny.
New Chair brings extensive experience in global pharmaceutical and biotechnology leadership, healthcare innovation, and strategic drug development.
🚀 New Article Alert! 🚀
The script-to-therapy journey for specialty meds is full of challenges. In this new Pharmaceutical Executive article, our CEO, Syam Palakurthy, shares key strategies to drive enhanced access and better outcomes.
At SamaCare, our mission is to simplify the prior authorization process so patients can start therapy sooner. We're proud to be featured and highlight how the landscape is evolving to overcome these barriers.
Big thanks to Pharmaceutical Executivef or the feature!
Read the full article here: https://lnkd.in/ed-xQmSN
#PharmaInnovation #PatientAccess #PriorAuthorization #SpecialtyDrugs
Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

